Feed/Investors/Dynagrow Capital, LLLP

Dynagrow Capital, LLLP

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-10-01

ROUNDS

as lead investor

LED ROUNDS · USD

$8M

across 1 round

LATEST ROUND

Series A · $8M · 2026-10-01

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Dynagrow Capital, LLLP: led 1 round · Fireround

Company	Round	Amount	Announced	Role
Vinci Pharmaceuticals Inc. Vinci Pharmaceuticals is disrupting retinal disease treatment with EPIPLANT™, a proprietary needle free drug delivery platform.	Series A Verified against 4 of 7 sources	$8M	2026-10-01	[ LEAD ]